What are the normal physiological postprandial levels of glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) in a healthy adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Physiological Postprandial GLP-1 and GLP-2 Levels in Healthy Adults

In healthy adults, basal GLP-1 levels range from 0.4 to 1.4 pM, with maximal postprandial peaks reaching 10-12 pM approximately 30-60 minutes after meal ingestion 1. For GLP-2, basal levels are approximately 19-27 pmol/L, with postprandial responses showing a meal-stimulated area under the curve of approximately 7,151-12,801 min × pmol/L over 180 minutes 2.

GLP-1 Postprandial Response

The GLP-1 response exhibits distinct characteristics depending on nutrient composition:

  • Basal (fasting) levels: 0.4-1.4 pM in healthy individuals 1
  • Peak postprandial levels: 10-12 pM 1
  • Timing of peak: Typically occurs 30-60 minutes after meal ingestion 1
  • Response pattern: Biphasic release with peaks at 30-60 minutes following oral glucose administration 1

Nutrient-Specific Responses

The magnitude and duration of GLP-1 secretion varies substantially by macronutrient:

  • Fat: Produces the strongest and most prolonged GLP-1 response (>120 minutes) 1
  • Carbohydrates: Generate an acute, short-term response (maximum 60 minutes) 3
  • Mixed meals: Induce rapid GLP-1 increase peaking at 5 minutes with declining levels after 30 minutes 1
  • Amino acids: Also trigger rapid plasma GLP-1 response 1

A critical caveat: Intravenous glucose does not stimulate GLP-1 release, confirming that luminal nutrient contact is essential for secretion 1. This occurs through nervous reflexes and putative humoral factors released from the upper small intestine, in addition to direct nutrient stimulation of L cells 1.

GLP-2 Postprandial Response

GLP-2 follows a similar but distinct pattern:

  • Basal levels: 19-27 pmol/L (median 23 pmol/L with 25-75% range) 2
  • Meal-stimulated AUC: 7,151-12,801 min × pmol/L over 180 minutes 2
  • Secretion pattern: Released postprandially from L cells located predominantly in the ileum 2

Important Clinical Considerations

Sex Differences

Postprandial responses show sex-specific patterns, with glicentin levels higher in females while glucagon and major proglucagon fragment levels are higher in males 3. This suggests hormonal or physiological differences in proglucagon processing between sexes.

Obesity Effects

Individuals with obesity demonstrate blunted postprandial glicentin secretion compared to normal-weight individuals 3, though the overall proglucagon-derived peptide responses remain elevated with higher energy content meals regardless of weight status 3.

Diabetes Impact

In type 2 diabetes, the relative postprandial increase in insulin secretion mediated by endogenous GLP-1 remains comparable to non-diabetic subjects (approximately 44-47% increase), and GLP-1 accounts for approximately 25-27% of postprandial insulin secretion 4. However, patients with higher HbA1c levels show lower GLP-1 responses to meals 5.

Measurement Timing

The 60-minute GLP-1 incremental AUC serves as a clinically relevant marker, showing inverse correlation with glycemic control and meal-induced hyperglycemia 5. This timepoint captures the peak physiological response while being practical for clinical assessment.

Methodological Pitfall

The paracetamol absorption test, previously used to assess gastric emptying and indirectly GLP-1 effects, is now considered suboptimal 6. Scintigraphy represents the gold standard for measuring gastric emptying and should be used when precise assessment is required 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.